Hyperfine initiated with a Hold at Jefferies

Jefferies analyst Young Li initiated coverage of Hyperfine with a Hold rating and $1.25 price target. While the company’s Swoop portable MRI is unique, differentiated, and has advantageous features, it is still in the very early stages of commercialization and lacks predictability in the selling cycle as each sale is still unique, the analyst tells investors in a research note. The firm’s survey results show good awareness of Swoop but incremental increases in expected purchases through 2029.